Concepedia

Author

Yun-Peng Yang

Sun Yat-sen University

Also Known As

YUNPENG YANG, Yun-Peng Yang, Yun-peng Yang, Yunpeng Yang

15

Publications

231

Citations

9

H-Index

16

Concepts

All Affiliations

Sun Yat-sen UniversitySun Yat-sen University Cancer CenterState Key Laboratory of Oncology in South ChinaFirst Affiliated Hospital of Guangzhou University of Chinese MedicineFifth Affiliated Hospital of Sun Yat-sen University
YY

About

Yun-Peng Yang is an author at Sun Yat-sen University specializing in drug discovery, molecular dynamics, and molecular simulation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

1

1

12

2

Natural Sciences

1

1

12

3

Biochemistry

1

1

12

4

Molecular Biology

1

1

12

5

Molecular Sciences

1

1

12

Yun-Peng Yang

×

9

Publications

208

Citations

9

H-Index

YearCitations

Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo

Yuanyuan Zhao, Ying Tian, Jing Zhang,

Drug Design Development and Therapy

2014

47

Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs

Sheng Jin, Yun-Peng Yang, Yuxiang Ma,

PLoS ONE

2016

39

A retrospective analysis of the clinicopathological and molecular characteristics of pulmonary blastoma

Yuanyuan Zhao, Lin Liu, Ting Zhou,

OncoTargets and Therapy

2016

24

The Efficacy and Toxicity of Lobaplatin-contained Chemotherapy in Extensive-stage Small-cell Lung Cancer

Ning-Ning Zhou, Yuanyuan Zhao, Lin-Zhu Zhai,

Journal of Cancer

2018

24

Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies

Sheng Jin, Ya-Xiong Zhang, Xiao-Bo He,

The Oncologist

2016

18

The Good Pain Management (GPM) Ward Program in China and its impact on Chinese cancer patients: the SYSUCC experience

Yun-Peng Yang, Yuxiang Ma, Yan Huang,

Chinese Journal of Cancer

2014

17

Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma

Jianwei Zhang, Tao Qin, Shao-Dong Hong,

Chinese Journal of Cancer

2015

14

Sacituzumab Tirumotecan in EGFR-TKI–Resistant, <i>EGFR</i> -Mutated Advanced NSCLC

Wenfeng Fang, Lin Wu, Xiangjiao Meng,

New England Journal of Medicine

2025

13

Computational analysis for residue-specific CDK2-inhibitor bindings

Yun-Peng Yang, Liping He, Jing-xiao Bao,

Chinese Journal of Chemical Physics

2019

12

Page 1